Quantbot Technologies’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-26,641
Closed -$445K 2228
2022
Q4
$445K Buy
+26,641
New +$450K 0.03% 611
2022
Q2
Sell
-45,139
Closed -$500K 2287
2022
Q1
$500K Buy
45,139
+6,350
+16% +$71.1K 0.04% 570
2021
Q4
$681K Sell
38,789
-29,296
-43% -$568K 0.06% 453
2021
Q3
$1.38M Buy
68,085
+20,568
+43% +$529K 0.1% 287
2021
Q2
$1.57M Buy
47,517
+7,478
+19% +$282K 0.12% 242
2021
Q1
$1.56M Buy
+40,039
New +$1.88M 0.15% 188
2020
Q4
Sell
-17,409
Closed -$493K 1799
2020
Q3
$493K Buy
17,409
+12,385
+247% +$391K 0.06% 358
2020
Q2
$182K Buy
+5,024
New +$142K 0.02% 455

Quantbot Technologies's ONEM Position: Q1 2023 in Review

Quantbot Technologies sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 26,641 shares — an estimated $445K sold.

Quantbot Technologies first reported a position in ONEM in Q2 2020 and held it in 8 quarters. The position peaked at $1.57M in Q2 2021. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Quantbot Technologies reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Quantbot Technologies sold 26,641 1Life Healthcare shares in Q1 2023, an estimated $445K.
  • Quantbot Technologies first reported a position in 1Life Healthcare in Q2 2020 and held it in 8 quarters.
  • Quantbot Technologies's 1Life Healthcare position peaked at $1.57M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Quantbot Technologies's 13F filing for Q1 2023, filed 12 May 2023.